SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-327128
Filing Date
2021-11-12
Accepted
2021-11-12 06:14:05
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d239669d10q.htm   iXBRL 10-Q 1302720
2 EX-31.1 d239669dex311.htm EX-31.1 6888
3 EX-31.2 d239669dex312.htm EX-31.2 6879
4 EX-32.1 d239669dex321.htm EX-32.1 3509
5 EX-32.2 d239669dex322.htm EX-32.2 3446
  Complete submission text file 0001193125-21-327128.txt   4358411

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vinc-20210930.xsd EX-101.SCH 28592
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vinc-20210930_cal.xml EX-101.CAL 30559
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vinc-20210930_def.xml EX-101.DEF 126923
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20210930_lab.xml EX-101.LAB 279748
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20210930_pre.xml EX-101.PRE 223513
11 EXTRACTED XBRL INSTANCE DOCUMENT d239669d10q_htm.xml XML 489123
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39244 | Film No.: 211399060
SIC: 2834 Pharmaceutical Preparations